Opus Genetics, Inc. · NASDAQ:IRD
Magrath George exercised options for 392,157 Opus Genetics, Inc. shares (Form 4)
Traded Sep 9, 2026 · Filed Sep 11, 2026
On Sep 9, 2026, Magrath George (Director, Chief Executive Officer) exercised options for 392,157 Opus Genetics, Inc. shares at US$1.15 for US$451K, leaving 2,048,485 shares. Filed Sep 11, 2026 (Form 4).
- Options exercised
- 392,157 shares
- Price
- US$1.15
- Value
- US$451K
- Holding after
- 2,048,485 shares
- Trading plan
- No
- Role
- Director, Chief Executive Officer
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Sep 9, 2026 | Common Stock | Option exercise | 392,157 | US$1.15 | 2,124,026 | Direct |
| Sep 9, 2026 | Common Stock | Shares withheld for tax | 75,541 | US$5.97 | 2,048,485 | Direct |
Source
Related
- Opus Genetics, Inc.
- Magrath George
- Opus Genetics, Inc. shareholders
- Form 4 · Magrath George · Jul 27, 2026
- Form 4 · Magrath George · Apr 27, 2026
- Form 4 · Foundation Fighting Blindness Retinal Degeneration Fund · Oct 2, 2026
- Form 4 · Gallagher Cam · Sep 8, 2026
- Form 4 · Gagnon Robert E. · Sep 8, 2026
- Schedule 13G/A · Balyasny Asset Management L.P. · Aug 14, 2026
- Schedule 13G/A · Perceptive Advisors LLC · Aug 14, 2026